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Background: The number of papers on the health related quality of life of patients with DM has grown in recent
years but fewer studies have drawn comparisons between diabetic persons and the general population considering
different risk groups. The aim of this study is to examine health related quality of life (HRQOL) in people with
diabetes mellitus (DM) and to analyze the differences in HRQOL adjusting by vascular risk.
Methods: The data used in this analysis was obtained from the responses of 15,926 individuals who participated in
the 2006 Catalonia Health Survey. Our analysis provides a number of multivariate statistical models designed for
studying HRQOL, based on the EQ-5D questionnaire, controlling for demographic factors of survey participants and
variables that identify diagnosed illnesses and health problems.
Results: Our findings suggest there is a significant, moderate negative relationship between DM and HRQOL in
comparison with non diabetic people (absolute value of the coefficient ranges between −0.04 and −0.054 points
on a scale of 1). A further analysis of subgroups reveals that diabetics who have not had vascular risk factors neither
vascular diseases do not have a diminished HRQOL when compared to the non-diabetic population in general,
when other factors are controlled for. In contrast, a comparison of diabetics and non-diabetics who exhibit vascular
disease or risk factors for vascular disease reveals HRQOL is significantly diminished to a greater extent for those
with diabetes (between 0.152 and 0.175 points loss when comparing a non-diabetic person with a diabetic with
vascular disease). Also, HRQOL in diabetic patients who have additional risk factors or a vascular disease are lower
than people non-diabetic who have additional risk factors or a vascular disease. When we focus our analysis to the
EQ-5D dimensions, we observe that diabetic persons who are neither at risk for nor have a diagnosed vascular
disease are no more likely than non-diabetics to report problems. However, diabetic patients who have additional
risk factors for vascular disease or a diagnosed vascular disease are significantly more likely to report moderated or
severe problems in 4 of the 5 dimensions of EQ-5D.
Conclusions: The HRQOL of a person who has diabetes is not necessarily lower than for a non-diabetic. Control of
risk factors associated to vascular diseases is a key factor for an enhanced quality of life. Vascular disease or risk
factors for vascular disease, on the other hand, are associated with a significantly diminished quality of life for
diabetic persons.Background
DM, whether Type 1 or Type 2, is a chronic disease with
a high prevalence rate among the world’s population that
increases mortality of the people who suffer from it [1].
Within a global framework, it has been estimated that
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reproduction in any medium, provided the or171 million. This number is predicted to reach 366 mil-
lion by 2030 [2], with 90% of the cases being Type 2.
According to the World Health Organization [3], this
disease causes 3.2 million deaths a year when deaths
from other causes attributable to complications from
diabetes are included and it generates substantial health
and social welfare costs [4-7].
A person with diabetes may have medical problems
caused by acute complications of the disease, such as
diabetic ketoacidosis or hyperglycemic hyperosmolar, or
as a result of adverse effects of medication, causing ford. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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chronic complications related to diabetes that increase a
diabetic person’s chances of premature death from dis-
eases caused by diabetes, which may be cardiovascular,
cerebrovascular, or affect the kidneys [8,9]. Moreover,
the quality of life of patients who have diabetes is dimin-
ished as a result of the aforementioned problems, and
others, such as loss of vision due to diabetic retinopathy
or amputations due to peripheral vascular diseases or
neuropathy, among other problems [10,11].
Given the complications that DM poses insofar as it
encroaches on a person's ability to live a life without
limitations as well as the significant rise in the mortality
rate of this disease and/or complications arising there-
from, a study on how diabetes mellitus affects the lives
of people who suffer from it is of great interest. The
number of papers on the quality of life of patients with
DM has grown in recent years; the majority have been
studies limited to adult populations with Type 2 dia-
betes. Far fewer studies have drawn comparisons be-
tween diabetic persons and the general population or
made use of the data from general health surveys in
order to compare different risk groups [12-22]. The
main objectives of this study are to analyze the HRQOL
of patients with DM, compare their situation to that of
the general population by using data from the general
health survey, and to compare the HRQOL of different
risk groups.
Methods
The data used in the analysis of health-related quality of
life were obtained from the 2006 Health Survey of Cata-
lonia (CHS), which was used to gather information on
the general health of non-institutionalized adults (16 or
more years of age). The CHS microdata were provided
to the authors by the Department of Health of the Gen-
eralitat (Government) of Catalonia. Microdata are pro-
vided for research purposes with the only requirement
to complete an application form that explains the aim of
the research.
Participants in the survey spent most of the year resid-
ing in family dwellings that were their habitual resi-
dences. Individuals were excluded if they resided in
group homes or were hospitalized at the time of the sur-
vey. The CHS is representative for each one of the 37
health areas existing in Catalonia with a maximum esti-
mation error of ± 5%. The CHS was made jointly by the
Department of Health and the Catalan Institute of Sta-
tistics. A random multistage stratified sample was
obtained with two stages, first health region and second
municipality. The CHS is also representative of regional
populations by sex and age groups and it was conducted
by specialized interviewers through personal interviews.
Individuals interviewed were selected by simple randomextraction process without replacement of the Popula-
tion Register of Catalonia. To avoid sample loss between
the theoretical and effective people interviewed five
people were selected for each person interviewed for
possible substitution according to a strict protocol to re-
place losses [23]. Adult responses were obtained from
15,926 persons.
The ESCA used the EQ-5D, a well-known generic
HRQOL instrument, which consists of five dimensions:
mobility, self- care, usual activities, pain/discomfort and
anxiety/depression. HRQOL is measured on three levels
in regard to functional state (no health problems, some
health problems and extreme health problems), resulting
in 243 aggregate combinations. Participants were sur-
veyed on the five dimensions of EQ-5D and each obser-
vation was translated to a single health score using the
Spanish time trade-off (TTO) value set [24,25]. The
Spanish value set have scores ranging from −0.653 to 1,
where 1 corresponds to a perfect state of health and 0
corresponds to death.
CHS also provides additional variables that could be
associated with health-related quality of life: socio-
demographic factors (age, gender, level of educational),
previously diagnosed diseases or chronic conditions
(vascular disease, rheumatic disease, digestive diseases,
mental illness, respiratory disease, diabetes mellitus,
musculoskeletal diseases), risk factors (hypertension and
hypercholesterolemia) and negative health experiences
(undergoing hospitalization) and lifestyle (smoking, alco-
hol intake).
Given the nature of the dependent variable, we per-
form a multivariate analysis for identifying variables for
predicting HRQOL scores reported by the health survey
participants. Our empirical strategy starts with a basic
model construct (Model 1) that uses control variables
such as age, sex, previously diagnosed disease, and
health problems (diabetes mellitus, risk of vascular dis-
ease, vascular disease, musculoskeletal disease, digestive
disease, mental illness, other diseases, and report of an
accident in the last 12 months). The variable “risk of
vascular disease” receives a score of 1 if the person is
obese (BMI ≥ 30 kg/m2), has hypertension or abnormal
cholesterol levels; otherwise the score is 0.
As an abundant literature indicates, hypertension,
obesity and hypercholesterolemia represent a higher vas-
cular risk, for both non-diabetic population and for
people with diabetes [26-34]. Although we have no clin-
ical measures on levels of blood pressure or cholesterol,
data collected provide information on whether a person
has been diagnosed with hypertension or hypercholester-
olemia and self referred height and weight. The inclusion
of this variable can provide interesting results on the in-
fluence of these factors of vascular risk in the QOL as
other studies have shown [35,36].
Table 1 Main characteristics of the sample





No studies completed 14.73%
Primary school completed 23.66%














Mental illness (anxiety/depression) 18.72%
Reported health risks
Risk alcohol intake 4.63%
Smoker 28.25%
Ex-smoker 19.40%
lllegal Drug user 8.39%
Table 2 Distribution of dependent variables
Dependent variables Percentage/ average
(standard desviation)
EQ-5D score 0.857 (0.264)
Moderate or extreme problem in EQ-5D
dimension 1 (Mobility)
16.96%
Moderate or extreme problem in EQ-5D
dimension 2 (Self-care)
6.29%
Moderate or extreme problem in EQ-5D
dimension 3 (Usual activities)
12.96%
Moderate or extreme problem in EQ-5D
dimension 4 (Pain/discomfort)
34.02%
Moderate or extreme problem in EQ-5D
dimension 5 (Anxiety/depression)
20.21%
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if the respondent has been diagnosed with or has ische-
mic heart disease or has had an embolism. Data on other
less common vascular diseases has not been collected in
this survey. Model 2, which is built upon Model 1, adds
a host of demographic factors such as marital status and
level of education. Model 3, in turn, provides additional
data on lifestyle (excessive drinking, smoking, illegal
drug use).
Due to the continuous nature of the dependent vari-
able, we performed regression models with heteroske-
dasticity robust least squares estimate by applying the
Eicker-White Heteroskedasticity Consistent Covariance
Matrix Estimate [37] so that the inference procedures
are valid even where the error terms have non constant
variance among survey participants.
Furthermore, the two-fold objective of this study led
us to construct two versions of each model. In the first
version (A), previously diagnosed DM is used as an ex-
planatory variable in the multivariate analysis on the
dependent variable where we contrast if diagnosed DM
is associated with a lower health-related quality of life.
The second version (B) identifies persons who have been
diagnosed of diabetes but have neither had not previ-
ously been diagnosed with any other vascular disease (is-
chemic heart disease or embolism) and do not exhibit
any reported risk factors (obesity, high cholesterol,
hypertension) and compares them to diabetic patients
who are at risk for vascular disease and those who have
had or have been diagnosed with vascular disease. In
addition, control and comparison variables have been
introduced by including data on persons who do not
have diabetes but are at risk for vascular disease and
others who do not have diabetes but have had or have
previously been diagnosed with vascular disease. So,
Model B can be interpreted as analysis of subgroups.
Lastly, a detailed analysis is performed on each of the
dimensions that comprise the research instrument for
assessing quality of life (mobility, self-care, usual activ-
ities, pain/discomfort and anxiety/depression). The prob-
ability of reporting a problem as moderate or extreme
for each of the dimensions of the EQ-5D is therefore
analyzed using the same explanatory variables from
Model 3 as control variables. Given the nature of each of
the variables studied (dichotomous variables that receive
a score of 1 if the individual identifies a problem in the
dimension under study or a score of 0 where no prob-
lem is indicated) the analysis is carried out using discrete
choice models of the probit type.
Results
Tables 1 and 2 show the main characteristics of the sam-
ple group under analysis. General population report the
pain/discomfort dimension as being the most frequentin terms of moderate/extreme problems (34.02%), with
moderate/extreme problems being the least frequent
(6.29%) in the self-care dimension. Average age was
47.4 years old. A 49.5% of the sample were men. A
14.7% of the sample had no studies completed, 23.7%
had primary school studies, 46.5% secondary school
studies and 15.1% tertiary studies. Only 6.40% of the
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muscular problems are the most reported (46.85%). A
10.2% of the sample was diagnosed of a vascular disease
and a 37.8% presented vascular risk.
The EQ-5D average score of the sample is 0.857 (with
a standard deviation of 0.264). A 16.96% of the sample
reported moderate or severe problems in the dimension
of mobility. A 6.29% in the dimension of self-care. A
12.96% in the dimension of usual activities. A 34.02% in
the dimension of pain/discomfort. And, finally, a 20.21%
of the sample reported moderate or severe problems in
the dimension of anxiety/depression.
Results of the empirical analysis are contained in
Tables 3 and 4. If we focus our attention on the Type A
models, we observe that diabetes mellitus is a significant
variable that has a negative relationship with health-
related quality of life. The absolute value of the coefficient
ranges between 0.04 and 0.054 points on a scale of 1
which indicates a moderately diminished HRQOL com-
pared to non-diabetic persons after controlling for other
factors. Risk factors for vascular disease are similarly asso-
ciated with a significant drop in HRQOL, although the ab-
solute value of the coefficient is low. Lastly, the variable
“previously diagnosed vascular disease” is clearly signifi-









Diabetes without additional risk factors or vascular disease
Diabetes with risk factors for vascular disease
Risk factors for vascular disease without diabetes
Diabetes with vascular disease




*** Significant variable 99% CI ** Significant variable 95% CI.
Model 1: control variables: sex, age, diseases; Model 2: control variables: sex, age, d
diseases, marital status, level of education, alcohol intake, smoking habit, illegal dru
Version B of the Models. Reference group characteristics: Non-diabetic, no risk facto
Marginal Effects from Empirical Models.that of the variable “diabetes”, as it falls between 0.076 and
0.1, on a scale of 1, compared with persons who do not
have this disease, after controlling for other factors.
Results for the Type A models are fairly stable and indi-
cate that DM is associated to a moderate drop in HRQOL.
The loss of HRQOL in persons with DM is less than for
persons who have vascular disease and greater than the
loss of HRQOL when other risk factors are present.
The Type B models allow us to compare the HRQOL of
persons with DM based on the existence of other risk fac-
tors for vascular disease and in cases where vascular disease
is or is not present. The results indicate that persons who
have diabetes who are not at-risk for vascular disease and
have not previously been diagnosed with vascular disease
do not have a diminished HRQOL when compared to the
rest of the population, after controlling for other factors
(age, sex, other diseases, sociodemographic variables and
lifestyles). Although the coefficient has a negative value, it is
nearly zero and is not statistically significant.
However, in the case of a diabetic person who has add-
itional risk factors for vascular disease, HRQOL drops
significantly when compared to a non-diabetic who is
not at-risk (a loss of 0.05-0.06 points). Similarly, a com-
parison of the loss of HRQOL in a diabetic patient who
has additional risk factors for vascular disease and aModel 1 Model 2 Model 2 Model 3 Model 3
Version B Version A Version B Version A Version B
−0.0406 −0.0458
* (0.0099) *** (0.0094) ***
−0.0056 −0.0116
* (0.0040) (0.0037) ***
−0.0851 −0.0756




(0.0127) *** (0.0126) *** (0.0119) ***
−0.0104 −0.0066 −0.0128
(0.0041) ** (0.0041) (0.0038) ***
−0.1751 −0.1516 −0.1535
(0.0217) *** (0.0209) *** (0.0211) ***
−0.0959 −0.0870 −0.0733
(0.0100) *** (0.0099) *** (0.0089) ***
15,926 15,919 15,919 15,455 15,455
315.45 207.92 195.07 162.13 154.11
0.386 0.4165 0.4041 0.3913 0.3831
iseases, marital status, level of education, Model 3: control variables: sex, age,
g use.
rs for vascular disease, and no diagnosed vascular disease.











Diabetes without additional risk factors
or vascular disease
0.0201 0.0181 0.0492 0.0775 0.0242
(0.0234) (0.0143) (0.0244) (0.0429) (0.0332)
Diabetes with risk factors for vascular
disease
0.1017 0.0211 0.0454 0.0916 0.0267
(0.0177) *** (0.0076) *** (0.0125) *** (0.0252) *** (0.0181)
Risk factors for vascular disease without
diabetes
0.0404 0.0064 0.0141 0.0470 0.0137
(0.0063) *** (0.0029) ** (0.0047) *** (0.0104) *** (0.0078)
Diabetes with vascular disease 0.1440 0.0519 0.1041 0.1224 0.0357
(0.0259) *** (0.0133) *** (0.0208) *** (0.0352) *** (0.0237)
Vascular disease without diabetes 0.0844 0.0269 0.0724 0.1189 0.0435
(0.0121) *** (0.0061) *** (0.0105) *** (0.0184) *** (0.0136) ***
Sample size 15,455 15,455 15,455 15,455 15,455
F Distribution 4467.4 1487.73 3259.74 5570.5 4688.82
Pseudo R2 0.3348 0.2529 0.301 0.2839 0.3086
*** Significant variable 99% CI. ** Significant variable 95% CI.
Reference group characteristics: Non-diabetic, no risk factors for vascular disease, and no diagnosed vascular disease.
Control variables: sex, age, diseases, marital status, level of education, alcohol intake, smoking habit, illegal drug use.
Marginal Effects from Probit Models.
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disease, the loss in QOL is significantly greater for per-
sons who have diabetes. The loss of HRQOL is clearly
the greatest for diabetic patients who have been diag-
nosed with vascular disease. Compared to non-diabetic
persons that have not been diagnosed with a disease of
this type, the loss of HRQOL is statistically significant in
all three Type B models (between 0.152 and 0.175 points
loss). It is also significant that HRQOL of this group is
also lower than for non-diabetic group who had been
diagnosed with vascular disease.
When we focus our analysis to the EQ-5D dimensions,
we observe that diabetic persons who are neither at risk
for nor have a diagnosed vascular disease are no more
likely than those in the reference group (non-diabetics
with no risk factors or previously diagnosed vascular dis-
ease) to report problems in dimensions 1 (physical mo-
bility), 2 (self-care) 3 (usual activities) and 4 (pain/
discomfort). In contrast, diabetic patients who have add-
itional risk factors for vascular disease (obesity, hyper-
cholesterolemia, hypertension) or a diagnosed vascular
disease are significantly more likely to report in each of
the 4 dimensions than the individuals in the reference
group. Furthermore, diabetic persons who are at-risk for
vascular disease report more problems that non-
diabetics who are also at-risk, and diabetic persons who
have been diagnosed with vascular disease have more
problems than non-diabetics who have been diagnosed
with vascular disease.
Discussion and conclusions
Our findings reveal a significant inverse relationship be-
tween diabetes mellitus and health related quality of life.We should emphasize that problems are much more
pronounced in diabetic population who exhibit add-
itional risk factors for vascular disease and especially in
cases when vascular disease is already present. The in-
formation provided in our analysis of subgroups is espe-
cially valuable for health policy decision makers and
could serve as the basis for measures and healthcare pol-
icies [38].
The main result of this study is that the health-related
quality of life of persons who have diabetes need not be
lower than it is for non-diabetic persons. Managing dia-
betes mellitus by controlling blood glucose levels, blood
pressure, cholesterol levels and weight as well as imple-
menting preventative measures to avoid acute vascular
events are key factors that can lead to an enhanced qual-
ity of life. These results mirror those obtained in studies
performed in other countries [12-14,39,40] where dia-
betic people with healthy habits and less cardiovascular
risks report substantially better HRQOL.
However, a key aspect or our study is that our empir-
ical results are not only statistically significant, but given
the magnitudes of the negative effect of vascular risk
and vascular disease on the quality of life of diabetic
people, in comparison with non diabetic people and dia-
betic people with no additional risks, they are also clinic-
ally relevant. The observed changes in HRQOL are
much higher than the values often cited in international
literature as the minimal clinically important difference
where responder definitions for the EQ-5D TTO ranged
from 0.074 to 0.08 [41,42]. Results that are statistically
and clinically significant might be robust enough to
serve as the basis for health policies that could benefit
wide population groups. In addition, vascular risk and
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significant worsening in the EQ-5D dimensions relating
to pain/discomfort, mobility, self-care and usual activ-
ities. In contrast, we do not identify statistically signifi-
cant differences between diabetic and non-diabetic
people when it comes to self perceived mental health,
after controlling for other factors. This result is consist-
ent with other previous papers [21,39,43].
Certain limitations in this study must be mentioned.
Firstly, in spite of the robust set of explanatory variables,
the cross-sectional nature of the data does not allow us
to perform a longitudinal analysis of the state of health
of respondents over a period of time. This is of great im-
portance because the study focuses on the quality of life
for the years lived, but diseases of the circulatory system
comprise the leading cause of death in Spain and is one
of the top 3 causes of years of potential life lost (YPLL).
Longitudinal data bases (questionnaires or administra-
tive data bases) allow for an analysis of not only the loss
in quality of life but the differences in life expectancy be-
tween diabetic and non-diabetic population, while con-
trolling for other risk factors and diagnosed vascular
disease, for the purpose of calculating the Adjusted Life
years for diabetic and non-diabetic persons [44-46]. Sec-
ondly, body mass index (BMI) was calculated based on
self-reported data on height and weight provided by sur-
vey respondents, thereby making responses susceptible
to potential bias inherent in how respondents perceive
themselves [47-50]. Similarly, there may be people with
diabetes who have not been diagnosed with the disease.
Therefore, the conclusions of the analysis should be lim-
ited to people who know they are diabetic. Also, it would
be interesting to have information on the time since
diagnosis of DM, vascular risks or vascular diseases to
avoid the confounding effects that cardiovascular risk
may introduce in the estimates.
It should be stressed that the CHS doesn’t allow us to
perform a separate analysis for people with type 1 and
type 2 DM. It is expected that most of the diabetic
people involved in the survey present type 2 Diabetes.
However, it is not possible to confirm this point. There-
fore, the accuracy of the results achieved in this study
and the differentiation of the effect of vascular risk and
vascular diseases in people with type 1 and type 2 dia-
betes is a line of research to focus future analysis.
Finally, a further limitation of our analysis is that,
when incorporating vascular risk factors to evaluate
HRQOL of patients with diabetes, we did it from the
data at our disposal from the CHS, which do not fol-
low the pattern of a recognised clinical measure, as
the Framingham or SCORE scores. CHS is a general
health survey that does not provide us these clinical
scores. Data collected provide information on whether
a person has been diagnosed with hypertension orhypercholesterolemia and self referred height and weight
but not on clinical levels of blood pressure or cholesterol
or on the measured height and weight. A future line of
research would be to analyze the combined effect of dia-
betes, hypertension, obesity and hypercholesterolemia
on health related quality of life in a group of people
where the variables of interest were measured under cri-
teria and clinical parameters.
The main objective of this study was to examine
HRQOL in people with DM and to ascertain data that
would be important for both individuals who have DM,
and healthcare decision makers. This information should
prove useful for achieving adequate healthcare for per-
sons with diabetes mellitus, starting off by providing
them with the necessary tools and resources for acquir-
ing a better understanding of the significance of their
health condition and to become experts on how to han-
dle the disease itself; such a disease management pro-
gram for type 2 diabetes patients can improve their
HRQOL [51]. In time we hope that this information will
prove useful to healthcare policy makers, serving as a
basis on which to make decisions regarding the efficient
allocation of resources.
Within the policy making realm this data could be
included in the process to develop a Health Strategy in
which the first step would be to provide sufficient epi-
demiological data for identifying key health problems of
the region or country under study, which would include
information on the prevalence and incidence of diabetes,
potential years of life lost (or gained) and mortality rates,
disabilities that were avoided or developed, and gains or
losses in HRQOL. Secondly, information about costs
associated with DM and related chronic complications
(employing a broad concept of costs that includes losses
in labour production, social costs associated with the
loss of independence, and healthcare spending) could be
used as an approximation of the loss in social welfare
these diseases cause. The third step would be to have in-
formation available on the technical and human
resources that could be employed in policies or plans of
action that affect primary, secondary and tertiary pre-
ventive measures aimed at DM and its complications.
After these steps have been taken, a logical move would
be to identify programs and measures across different
areas that are efficient, namely policies that lead to
improved life expectancy and quality of life for those
who suffer from these diseases while reducing the bur-
den they pose on available resources. Subsequently,
these measures should be put into operation and
evaluated.
Thus, a series of health-related measures in various
areas (healthcare, education, etc.) that are scientifically
proven to be effective and efficient at improving the situ-
ation of the population whose health is affected by
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invaluable tool on which to base healthcare policy deci-
sions about the allocation of resources (evidence-based
policies). Knowledge of the diminished health-related
quality of life in persons with diabetes mellitus should
be among the indicators that health policy decision
makers consider if they aim to formulate health policies
that are efficient from a social perspective.
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